Skip to main content
eXit

ImmunoSensation leaves X

Due to recent developments, we decided to discontinue our activities on the social media plattform X. With this decision, we follow more than 60 german universities and other research institutions. As a Cluster of Excellence, we see the communication of research and scientific results as well as their discussion as one of our tasks, which is why we did not make this decision lightly. However, X's line is not compatible with the basic values that we represent and also want to live in our communication. These include transparency, constructive discourse and, above all, scientific integrity.

We are looking forward to welcome you on our channels at

Bluesky

LinkedIn

Instagram

facebook

youtube

 

Related news

Scientists of the Femmunity Study at the Femmunity Café

News categories: Outreach

Femmunity Café brings science to the city

With the "Femmunity Café", a new Science Communication format opened its doors in Bonn on September 5th. The series offers a unique opportunity for the public to engage with scientists on the menstrual cycle, immunity, and women’s health. The event blends a relaxed café atmosphere with expert knowledge, creating a space where curiosity and conversation around topics mostly not publicly discussed are welcomed and current scientific insights are made excessible to everyone.
View entry
Wachten lab

News categories: Publication

Fat cells under false command

Too much fat can be unhealthy: how fat cells, so-called adipocytes, develop, is crucial for the function of the fat tissue. That is why a team led by researchers from the University Hospital Bonn (UKB) and the University of Bonn investigated the influence of primary cilia dysfunction on adipocyte precursor cells in a mouse model. They found that overactivation of the Hedgehog signaling pathway causes abnormal development into connective tissue-like cells instead of white fat cells. Their findings have now been published in The EMBO Journal.
View entry
Prof. Dr. Kaan Boztug

News categories: Honors & Funding

Kaan Boztug awarded Novartis Prize

Prof. Dr. Kaan Boztug from the University Hospital Bonn (UKB) receives the Novartis Prize for Therapy-Relevant Immunological Research 2025. The expert in rare diseases of the immune system and blood formation conducted most of the research work that has now been honored in Vienna. His work was supported by an ERC Starting Grant (ImmunoCore, 2012-2018) and an ERC Consolidator Grant (iDysChart, 2019-2025), among others. The science prize, worth 10,000 € is divided into two parts this time and also goes to Prof. Dr. Evelyn Ullrich.
View entry

Back to the news overview